Published in Proc Natl Acad Sci U S A on February 13, 2006
Growth factors, matrices, and forces combine and control stem cells. Science (2009) 8.46
Complexity in biomaterials for tissue engineering. Nat Mater (2009) 4.38
Alginate: properties and biomedical applications. Prog Polym Sci (2012) 3.18
Growth factor delivery-based tissue engineering: general approaches and a review of recent developments. J R Soc Interface (2010) 2.69
Functional muscle regeneration with combined delivery of angiogenesis and myogenesis factors. Proc Natl Acad Sci U S A (2009) 2.29
Material-based deployment enhances efficacy of endothelial progenitor cells. Proc Natl Acad Sci U S A (2008) 1.96
Polymers to direct cell fate by controlling the microenvironment. Curr Opin Biotechnol (2007) 1.20
Engineering of multifunctional gels integrating highly efficient growth factor delivery with endothelial cell transplantation. FASEB J (2008) 1.11
High-content drug screening with engineered musculoskeletal tissues. Tissue Eng Part B Rev (2010) 1.10
The role of multifunctional delivery scaffold in the ability of cultured myoblasts to promote muscle regeneration. Biomaterials (2011) 1.09
Layered PLG scaffolds for in vivo plasmid delivery. Biomaterials (2008) 1.04
Locally delivered growth factor enhances the angiogenic efficacy of adipose-derived stromal cells transplanted to ischemic limbs. Stem Cells (2009) 1.00
Use of a novel collagen matrix with oriented pore structure for muscle cell differentiation in cell culture and in grafts. J Cell Mol Med (2008) 1.00
Human embryonic stem cell encapsulation in alginate microbeads in macroporous calcium phosphate cement for bone tissue engineering. Acta Biomater (2012) 0.98
Controlled architectural and chemotactic studies of 3D cell migration. Biomaterials (2011) 0.97
Design and fabrication of a biodegradable, covalently crosslinked shape-memory alginate scaffold for cell and growth factor delivery. Tissue Eng Part A (2012) 0.97
Transplantation of cord blood mesenchymal stem cells as spheroids enhances vascularization. Tissue Eng Part A (2012) 0.97
Gas-foaming calcium phosphate cement scaffold encapsulating human umbilical cord stem cells. Tissue Eng Part A (2011) 0.95
Stem cells for skeletal muscle regeneration: therapeutic potential and roadblocks. Transl Res (2013) 0.92
Growth, differentiation, transplantation and survival of human skeletal myofibers on biodegradable scaffolds. Biomaterials (2008) 0.89
Minimally invasive approach to the repair of injured skeletal muscle with a shape-memory scaffold. Mol Ther (2014) 0.87
Umbilical cord stem cell seeding on fast-resorbable calcium phosphate bone cement. Tissue Eng Part A (2010) 0.85
Biomaterial-based delivery for skeletal muscle repair. Adv Drug Deliv Rev (2014) 0.85
Mannitol-containing macroporous calcium phosphate cement encapsulating human umbilical cord stem cells. J Tissue Eng Regen Med (2011) 0.84
Biomimetic scaffolds for regeneration of volumetric muscle loss in skeletal muscle injuries. Acta Biomater (2015) 0.84
The development of high-throughput screening approaches for stem cell engineering. Curr Opin Chem Biol (2007) 0.84
The effect of polypyrrole on arteriogenesis in an acute rat infarct model. Biomaterials (2008) 0.83
Increased Survival and Function of Mesenchymal Stem Cell Spheroids Entrapped in Instructive Alginate Hydrogels. Stem Cells Transl Med (2016) 0.83
Engineering approaches toward deconstructing and controlling the stem cell environment. Ann Biomed Eng (2011) 0.83
Rapid release of growth factors regenerates force output in volumetric muscle loss injuries. Biomaterials (2015) 0.80
Injectable, Pore-Forming Hydrogels for In Vivo Enrichment of Immature Dendritic Cells. Adv Healthc Mater (2015) 0.78
Regenerative therapy and tissue engineering for the treatment of end-stage cardiac failure: new developments and challenges. Biomatter (2013) 0.78
Long-Duration Three-Dimensional Spheroid Culture Promotes Angiogenic Activities of Adipose-Derived Mesenchymal Stem Cells. Biomol Ther (Seoul) (2016) 0.78
Engineered matrices for skeletal muscle satellite cell engraftment and function. Matrix Biol (2016) 0.77
Matrix scaffolding for stem cell guidance toward skeletal muscle tissue engineering. J Orthop Surg Res (2016) 0.76
Microtissues in Cardiovascular Medicine: Regenerative Potential Based on a 3D Microenvironment. Stem Cells Int (2016) 0.76
Measurement of oxygen tension within mesenchymal stem cell spheroids. J R Soc Interface (2017) 0.76
Engineered composite fascia for stem cell therapy in tissue repair applications. Acta Biomater (2015) 0.75
ASC Spheroid Geometry and Culture Oxygenation Differentially Impact Induction of Preangiogenic Behaviors in Endothelial Cells. Cell Transplant (2014) 0.75
Prosurvival Factors Improve Functional Engraftment of Myogenically Converted Dermal Cells into Dystrophic Skeletal Muscle. Stem Cells Dev (2016) 0.75
Regulation of epithelial cell morphology and functions approaching to more in vivo-like by modifying polyethylene glycol on polysulfone membranes. PLoS One (2012) 0.75
Biomaterials for skeletal muscle tissue engineering. Curr Opin Biotechnol (2017) 0.75
Tissue engineering. Science (1993) 19.65
Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature (1997) 14.82
Promoter traps in embryonic stem cells: a genetic screen to identify and mutate developmental genes in mice. Genes Dev (1991) 13.28
Engineering vascularized skeletal muscle tissue. Nat Biotechnol (2005) 7.73
Myogenic satellite cells: physiology to molecular biology. J Appl Physiol (1985) (2001) 6.27
Tissue engineering--current challenges and expanding opportunities. Science (2002) 5.03
Alginate hydrogels as synthetic extracellular matrix materials. Biomaterials (1999) 4.69
Conversion of mdx myofibres from dystrophin-negative to -positive by injection of normal myoblasts. Nature (1989) 4.08
A common somitic origin for embryonic muscle progenitors and satellite cells. Nature (2005) 3.40
Syndecan-3 and syndecan-4 specifically mark skeletal muscle satellite cells and are implicated in satellite cell maintenance and muscle regeneration. Dev Biol (2001) 3.00
Proliferation of muscle satellite cells on intact myofibers in culture. Dev Biol (1986) 2.91
HGF/SF is present in normal adult skeletal muscle and is capable of activating satellite cells. Dev Biol (1998) 2.65
Dynamics of myoblast transplantation reveal a discrete minority of precursors with stem cell-like properties as the myogenic source. J Cell Biol (1999) 2.50
Muscle-derived hematopoietic stem cells are hematopoietic in origin. Proc Natl Acad Sci U S A (2002) 2.39
The stem cell niche: theme and variations. Curr Opin Cell Biol (2004) 2.36
Cell-interactive alginate hydrogels for bone tissue engineering. J Dent Res (2001) 1.95
A role for nitric oxide in muscle repair: nitric oxide-mediated activation of muscle satellite cells. Mol Biol Cell (2000) 1.75
MyoD and Myf-5 differentially regulate the development of limb versus trunk skeletal muscle. Development (1997) 1.68
Muscle satellite (stem) cell activation during local tissue injury and repair. J Anat (2003) 1.67
Excitability and isometric contractile properties of mammalian skeletal muscle constructs engineered in vitro. In Vitro Cell Dev Biol Anim (2000) 1.61
Effect of fibroblast growth factor on the division and fusion of bovine myoblasts. J Cell Biol (1976) 1.52
The use of an antifibrosis agent to improve muscle recovery after laceration. Am J Sports Med (2001) 1.46
Hepatocyte growth factor affects satellite cell activation and differentiation in regenerating skeletal muscle. Am J Physiol Cell Physiol (2000) 1.44
TNF-alpha is a mitogen in skeletal muscle. Am J Physiol Cell Physiol (2003) 1.36
Antifibrotic effects of suramin in injured skeletal muscle after laceration. J Appl Physiol (1985) (2003) 1.28
ATP regulates the differentiation of mammalian skeletal muscle by activation of a P2X5 receptor on satellite cells. J Cell Biol (2002) 1.24
Suturing versus immobilization of a muscle laceration. A morphological and functional study in a mouse model. Am J Sports Med (1999) 1.19
The costs of musculoskeletal disease: health needs assessment and health economics. Best Pract Res Clin Rheumatol (2003) 1.16
Developmental fate of skeletal muscle satellite cells. Science (1979) 1.13
Skeletal muscle stem cells. Reprod Biol Endocrinol (2003) 1.13
Dissociation of heparan sulfate and receptor binding domains of hepatocyte growth factor reveals that heparan sulfate-c-met interaction facilitates signaling. J Biol Chem (2001) 1.10
Myoblast transplantation: the current status of a potential therapeutic tool for myopathies. J Muscle Res Cell Motil (2003) 1.10
Extracellular matrix, growth factors, genetics: their influence on cell proliferation and myotube formation in primary cultures of adult mouse skeletal muscle. Exp Cell Res (1995) 1.03
Regulation of satellite cells during skeletal muscle growth and development. Proc Soc Exp Biol Med (1990) 1.00
Efficacy of myoblast transplantation in nonhuman primates following simple intramuscular cell injections: toward defining strategies applicable to humans. Exp Neurol (2002) 0.98
Hepatocyte growth factor (HGF) inhibits skeletal muscle cell differentiation: a role for the bHLH protein twist and the cdk inhibitor p27. J Cell Physiol (2000) 0.97
Skeletal muscle tissue engineering using isolated myoblasts on synthetic biodegradable polymers: preliminary studies. Tissue Eng (1999) 0.96
The exogenous administration of basic fibroblast growth factor to regenerating skeletal muscle in mice does not enhance the process of regeneration. Growth Factors (1996) 0.91
Musculoskeletal conditions affect millions. Arch Pathol Lab Med (2004) 0.87
Bioreactor perfusion system for the long-term maintenance of tissue-engineered skeletal muscle organoids. In Vitro Cell Dev Biol Anim (1998) 0.84
Successive injections in mdx mice of myoblasts grown with bFGF. Neuromuscul Disord (1996) 0.79
[Interleukin 10 and tumor necrosis factor alpha gene expression in respiratory and peripheral muscles. Relation to sarcolemmal damage]. Arch Bronconeumol (2002) 0.78
Growth factors, matrices, and forces combine and control stem cells. Science (2009) 8.46
Hydrogels for tissue engineering: scaffold design variables and applications. Biomaterials (2003) 7.15
Harnessing traction-mediated manipulation of the cell/matrix interface to control stem-cell fate. Nat Mater (2010) 5.36
Role of matrix metalloproteinases in delayed cortical responses after stroke. Nat Med (2006) 5.10
Engineering tumors with 3D scaffolds. Nat Methods (2007) 3.96
Highly stretchable and tough hydrogels. Nature (2012) 3.34
Alginate: properties and biomedical applications. Prog Polym Sci (2012) 3.18
Alginate hydrogels as biomaterials. Macromol Biosci (2006) 2.94
Growth factor delivery-based tissue engineering: general approaches and a review of recent developments. J R Soc Interface (2010) 2.69
Functional muscle regeneration with combined delivery of angiogenesis and myogenesis factors. Proc Natl Acad Sci U S A (2009) 2.29
Inspiration and application in the evolution of biomaterials. Nature (2009) 2.23
Transcriptional profiling of stroma from inflamed and resting lymph nodes defines immunological hallmarks. Nat Immunol (2012) 2.17
FRET measurements of cell-traction forces and nano-scale clustering of adhesion ligands varied by substrate stiffness. Proc Natl Acad Sci U S A (2005) 2.07
Cancer cell angiogenic capability is regulated by 3D culture and integrin engagement. Proc Natl Acad Sci U S A (2009) 2.07
Dual growth factor delivery and controlled scaffold degradation enhance in vivo bone formation by transplanted bone marrow stromal cells. Bone (2004) 2.05
Alginate type and RGD density control myoblast phenotype. J Biomed Mater Res (2002) 2.04
Spatio-temporal VEGF and PDGF delivery patterns blood vessel formation and maturation. Pharm Res (2006) 2.03
Infection-mimicking materials to program dendritic cells in situ. Nat Mater (2009) 2.00
Material-based deployment enhances efficacy of endothelial progenitor cells. Proc Natl Acad Sci U S A (2008) 1.96
Coating of VEGF-releasing scaffolds with bioactive glass for angiogenesis and bone regeneration. Biomaterials (2006) 1.88
Combined angiogenic and osteogenic factor delivery enhances bone marrow stromal cell-driven bone regeneration. J Bone Miner Res (2004) 1.83
Non-viral gene delivery regulated by stiffness of cell adhesion substrates. Nat Mater (2005) 1.83
Label-free biomarker detection from whole blood. Nat Nanotechnol (2009) 1.80
Endothelial cell modulation of bone marrow stromal cell osteogenic potential. FASEB J (2005) 1.79
Angiogenic effects of sequential release of VEGF-A165 and PDGF-BB with alginate hydrogels after myocardial infarction. Cardiovasc Res (2007) 1.77
Engineering growing tissues. Proc Natl Acad Sci U S A (2002) 1.76
Polymeric growth factor delivery strategies for tissue engineering. Pharm Res (2003) 1.74
Controlling alginate gel degradation utilizing partial oxidation and bimodal molecular weight distribution. Biomaterials (2005) 1.74
New materials for tissue engineering: towards greater control over the biological response. Trends Biotechnol (2008) 1.69
In situ regulation of DC subsets and T cells mediates tumor regression in mice. Sci Transl Med (2009) 1.65
Quantitative assessment of scaffold and growth factor-mediated repair of critically sized bone defects. J Orthop Res (2007) 1.64
Controlled growth factor delivery for tissue engineering. Adv Mater (2009) 1.63
VEGF scaffolds enhance angiogenesis and bone regeneration in irradiated osseous defects. J Bone Miner Res (2006) 1.63
Engineering vascular networks in porous polymer matrices. J Biomed Mater Res (2002) 1.60
Active scaffolds for on-demand drug and cell delivery. Proc Natl Acad Sci U S A (2010) 1.58
The tensile properties of alginate hydrogels. Biomaterials (2004) 1.57
Cyclic strain enhances matrix mineralization by adult human mesenchymal stem cells via the extracellular signal-regulated kinase (ERK1/2) signaling pathway. J Biomech (2003) 1.56
Bioinspired growth of crystalline carbonate apatite on biodegradable polymer substrata. J Am Chem Soc (2002) 1.51
Controlling rigidity and degradation of alginate hydrogels via molecular weight distribution. Biomacromolecules (2004) 1.44
Sustained vascular endothelial growth factor delivery enhances angiogenesis and perfusion in ischemic hind limb. Pharm Res (2005) 1.43
An alginate-based hybrid system for growth factor delivery in the functional repair of large bone defects. Biomaterials (2010) 1.42
Regulating myoblast phenotype through controlled gel stiffness and degradation. Tissue Eng (2007) 1.40
Role of vascular endothelial growth factor in bone marrow stromal cell modulation of endothelial cells. Tissue Eng (2003) 1.39
Designing alginate hydrogels to maintain viability of immobilized cells. Biomaterials (2003) 1.39
NF-κB inhibits osteogenic differentiation of mesenchymal stem cells by promoting β-catenin degradation. Proc Natl Acad Sci U S A (2013) 1.35
Integrated approach to designing growth factor delivery systems. FASEB J (2007) 1.35
Effects of a bone-like mineral film on phenotype of adult human mesenchymal stem cells in vitro. Biomaterials (2005) 1.34
Quantifying the relation between adhesion ligand-receptor bond formation and cell phenotype. Proc Natl Acad Sci U S A (2006) 1.34
Differentiation stage alters matrix control of stem cells. J Biomed Mater Res A (2008) 1.33
Salt fusion: an approach to improve pore interconnectivity within tissue engineering scaffolds. Tissue Eng (2002) 1.33
Effects of VEGF temporal and spatial presentation on angiogenesis. Biomaterials (2009) 1.32
Can tissue engineering concepts advance tumor biology research? Trends Biotechnol (2010) 1.32
Injectable preformed scaffolds with shape-memory properties. Proc Natl Acad Sci U S A (2012) 1.28
Effect of substrate mechanics on chondrocyte adhesion to modified alginate surfaces. Arch Biochem Biophys (2004) 1.26
Mechanical strain regulates endothelial cell patterning in vitro. Tissue Eng (2007) 1.26
Macroscale delivery systems for molecular and cellular payloads. Nat Mater (2013) 1.25
Temporally regulated delivery of VEGF in vitro and in vivo. J Biomed Mater Res A (2006) 1.23
Polymers to direct cell fate by controlling the microenvironment. Curr Opin Biotechnol (2007) 1.20
Polymers for pro- and anti-angiogenic therapy. Biomaterials (2007) 1.19
Protein-based signaling systems in tissue engineering. Curr Opin Biotechnol (2003) 1.16
Engineering RGD nanopatterned hydrogels to control preosteoblast behavior: a combined computational and experimental approach. Biomaterials (2007) 1.16
Fabrication and in vitro testing of polymeric delivery system for condensed DNA. J Biomed Mater Res A (2003) 1.15
Long-term in vivo gene expression via delivery of PEI-DNA condensates from porous polymer scaffolds. Hum Gene Ther (2005) 1.15
Enhancing microvascular formation and vessel maturation through temporal control over multiple pro-angiogenic and pro-maturation factors. Biomaterials (2013) 1.14
A bioinspired soft actuated material. Adv Mater (2013) 1.14
Sustained delivery of plasmid DNA from polymeric scaffolds for tissue engineering. Adv Drug Deliv Rev (2006) 1.13
In vivo time-gated fluorescence imaging with biodegradable luminescent porous silicon nanoparticles. Nat Commun (2013) 1.11
Locally enhanced angiogenesis promotes transplanted cell survival. Tissue Eng (2004) 1.10
Design of biodegradable hydrogel for the local and sustained delivery of angiogenic plasmid DNA. Pharm Res (2008) 1.10
Microenvironmental regulation of biomacromolecular therapies. Nat Rev Drug Discov (2007) 1.10
The role of multifunctional delivery scaffold in the ability of cultured myoblasts to promote muscle regeneration. Biomaterials (2011) 1.09
Designing scaffolds to enhance transplanted myoblast survival and migration. Tissue Eng (2006) 1.09
Nanoscale cell adhesion ligand presentation regulates nonviral gene delivery and expression. Nano Lett (2007) 1.09
Spatiotemporal delivery of bone morphogenetic protein enhances functional repair of segmental bone defects. Bone (2011) 1.09
Cyclic arginine-glycine-aspartate peptides enhance three-dimensional stem cell osteogenic differentiation. Tissue Eng Part A (2009) 1.09
Targeted delivery of nanoparticles to ischemic muscle for imaging and therapeutic angiogenesis. Nano Lett (2010) 1.08
The effect of sustained delivery of vascular endothelial growth factor on angiogenesis in tissue-engineered intestine. Biomaterials (2008) 1.07
Biomaterial delivery of morphogens to mimic the natural healing cascade in bone. Adv Drug Deliv Rev (2012) 1.07
Sustained release of multiple growth factors from injectable polymeric system as a novel therapeutic approach towards angiogenesis. Pharm Res (2009) 1.07
Cyclic tensile strain triggers a sequence of autocrine and paracrine signaling to regulate angiogenic sprouting in human vascular cells. Proc Natl Acad Sci U S A (2009) 1.06
Stress-relaxation behavior in gels with ionic and covalent crosslinks. J Appl Phys (2010) 1.06
Shape-defining scaffolds for minimally invasive tissue engineering. Transplantation (2004) 1.04
Identification of immune factors regulating antitumor immunity using polymeric vaccines with multiple adjuvants. Cancer Res (2014) 1.04
Spatiotemporal control over growth factor signaling for therapeutic neovascularization. Adv Drug Deliv Rev (2007) 1.03
Comparison of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in SCID mice. J Control Release (2003) 1.03
Tissue engineering strategies for in vivo neovascularisation. Expert Opin Biol Ther (2002) 1.02
External mechanical strain regulates membrane targeting of Rho GTPases by controlling microtubule assembly. Am J Physiol Cell Physiol (2002) 1.02
Upregulation of bone cell differentiation through immobilization within a synthetic extracellular matrix. Biomaterials (2007) 1.01
Noninvasive probing of the spatial organization of polymer chains in hydrogels using fluorescence resonance energy transfer (FRET). J Am Chem Soc (2007) 1.01
Promoting angiogenesis via manipulation of VEGF responsiveness with notch signaling. Biomaterials (2009) 1.00
Mimicking nature by codelivery of stimulant and inhibitor to create temporally stable and spatially restricted angiogenic zones. Proc Natl Acad Sci U S A (2010) 1.00
Performance and biocompatibility of extremely tough alginate/polyacrylamide hydrogels. Biomaterials (2013) 1.00
Improved bone healing by angiogenic factor-enriched platelet-rich plasma and its synergistic enhancement by bone morphogenetic protein-2. Int J Oral Maxillofac Implants (2008) 0.97
Integrin-adhesion ligand bond formation of preosteoblasts and stem cells in three-dimensional RGD presenting matrices. Biomacromolecules (2008) 0.97
Controlled architectural and chemotactic studies of 3D cell migration. Biomaterials (2011) 0.97
Fluorescent resonance energy transfer: A tool for probing molecular cell-biomaterial interactions in three dimensions. Biomaterials (2007) 0.96
Multi-scale modeling to predict ligand presentation within RGD nanopatterned hydrogels. Biomaterials (2005) 0.96